Bristol-Myers Squibb Company (NYSE:BMY) closed its last session at $55.23 with the change of -0.67%. The market capitalization of the company is $92.28B with an average Volume of 10.91 million shares. The stock currently has its 52-Week High range of $77.12 and 52-week low range of $55.02. The Price to Book (P/B) ratio stands at 6.23. The stock traded total quantity of 9.01 million shares.
Currently Bristol-Myers Squibb Company (BMY) captured an average recommendation of “ Overweight ” from analysts, according to FactSet data. The stock has been suggested as “Buy” from “10″ Analysts”. “1” rated “Sell” for the company. “13” said the company as a “Hold”. Overweight rating was given by “1” and Underweight rating was given by “1”.
Analysts are expecting that the company to achieve $68.46 Price Target in next 52-weeks, average price is come up through the consensus of analysts. High potential price target is set at $100.00 however minimum price target advised by analysts is $50.00. The Median price target for the stock is measured at $66.50.
Presently, Analysts decided consensus EPS estimate of $0.64 for present quarter and one month ago projected EPS estimate was at $0.64. If we take a look at back 3 month ago, consensus EPS estimate was $0.64.
A current consensus EPS estimate for next quarter is at $0.56 and 3 month ago EPS forecast was $0.57. Have a look at back 1 month ago, consensus EPS forecast was seen at $0.57.
For current fiscal year, most recent EPS estimate is set at $2.62 based on Analyst consensus and three month ago consensus EPS opinions was at $2.55. During period one month ago, consensus EPS forecast was decided at $2.60.
A current consensus EPS projection for next fiscal year is observed at $3.01 and one month ago consensus EPS forecast was at $3.04. Take a look at back three month ago, consensus EPS estimate opinions was decided at $3.23 by analysts.
One Month ago, the stock has gained consensus mean rating of Overweight based on the analysis of brokerage analyst firms polled. 10 presented the recommendations about the stock as a “Buy” signal and “Overweight” signal was reported by 1. 13 advised the “Hold” rating about this stock. 1 revealed “Sell” signal and “Underweight” rating was declared by 1.
Three Months Ago, Analysts recommended an average brokerage rating of Overweight derived from brokerage firms, according to FactSet. 13 said a “Buy Rating” and 1 announced “Overweight Rating”. 11 advised “Hold Rating” regarding the stock. 1 announced “Sell Rating” and 1 disclosed “Underweight Rating”.